Evidence map›Paper›PMID 42794447›Full record

ArticleInternational journal of molecular sciences2026

Development of Universal Primer Sets for Zika Virus Envelope Gene Amplification and Sequencing.

Léo Shigueki Sato, Yuki Tayama, Gabriel Gazzoni Araújo Gonçalves, Luiz Carlos Alves, Fábio André Brayner, Shangfan Hu, Mya Myat Ngwe Tun, Arata Hidano, Yuki Takamatsu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Léo Shigueki SatoDepartment of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0001-8971-2204
Yuki TayamaDepartment of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852-8523, Japan.
Gabriel Gazzoni Araújo GonçalvesKeizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
Luiz Carlos AlvesKeizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
Fábio André BraynerKeizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
Shangfan HuDepartment of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0001-5671-8319
Mya Myat Ngwe TunDepartment of Tropical Viral Vaccine Development, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0002-8986-6307
Arata HidanoDepartment of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0000-0003-1707-5319
Yuki TakamatsuDepartment of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852-8523, Japan.ORCID 0009-0008-6706-438X

Funding

Heiwa Nakajima Foundation NAJapan Agency for Medical Research and Development JP225fa627004, JP25wm0125006, JP25fk0108656, JP25wm0125011 and JP25fm0208101Japan Society for the Promotion of Science 24K02288Kurozumi Medical Foundation NAMinistry of Education, Culture, Sports, Science and Technology National BioResource Project
6 · The paper itself

Abstract

The Zika virus (ZIKV) remains an important public health concern owing to its association with neurological disorders and congenital abnormalities. Genetically, ZIKV is classified into two major lineages-African and Asian-and continues to evolve, with evidence of genetic diversification following its introduction into the Americas. The study of the envelope (E) gene of ZIKV is a key tool for understanding viral biology, phylogenetic analysis, and developing antiviral drugs and vaccine candidates. However, few studies have focused on designing primers capable of efficiently detecting and amplifying this essential gene. In this study, we developed universal primer sets capable of amplifying and sequencing the full-length ZIKV E gene across genetically diverse lineages and strains. Primers were designed based on representative ZIKV sequences available in public databases and validated using viral isolates and in vitro-spiked plasma samples. The assay demonstrated high specificity and analytical sensitivity, with the analytical detection limit established using serially diluted DNA amplicons from the target region. Furthermore, ZIKV was successfully detected in plasma samples spiked at 1 × 10

Indexed as

DNA PrimersViral Envelope ProteinsZika VirusZika Virus InfectionHumansPhylogenySequence Analysis, DNADNA PrimersViral Envelope Proteinsenvelope genelineageRT-PCRsequencingZika virus

Identifiers

PMID42794447
PMCPMC13607635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.